Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7100
+0.0400 (2.40%)
NASDAQ· Last Trade: Jun 4th, 11:35 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors